Corneal Transplantation: Types, Rejection and Recovery

Corneal transplantation replaces diseased layers of the clear front window of the eye with screened donor tissue. The purpose may be to improve optical clarity, preserve the eye, relieve pain or treat structural damage. The procedure does not guarantee normal vision or a graft that lasts for life.

Key Points

The surgeon should replace only the layers affected when a suitable lamellar technique is available.
Penetrating, anterior lamellar and endothelial transplants have different indications, recovery and complications.
Rejection can occur after apparent healing and requires urgent treatment.
Astigmatism, other eye disease and graft clarity can limit vision after technically successful surgery.
Long-term drops, checks and sometimes repeat surgery may be needed.

What the Cornea Does

The cornea contributes much of the eye’s focusing power and must remain transparent and regularly shaped. Its epithelium protects the surface, the stroma provides most thickness and shape, and the endothelium pumps fluid to maintain clarity.

Disease can affect one layer or the full thickness. Treatment choices depend on the damaged layer, scar depth, infection status, shape, endothelial function and the health of the retina and optic nerve.

Why a Transplant May Be Considered

Indications can include advanced keratoconus, Fuchs endothelial dystrophy, corneal scarring, failed previous graft, persistent swelling after surgery, severe infection or injury and selected inherited corneal disease. Many conditions have non-transplant options first.

Rigid or scleral contact lenses, corneal cross-linking, intracorneal rings, medicines or other procedures may be relevant depending on the diagnosis. A transplant should have a documented goal and comparison with alternatives.

Penetrating Keratoplasty

Penetrating keratoplasty replaces a full-thickness circular area and is secured with sutures. It may be used when disease or scarring spans multiple layers or when a layer-selective operation is unsuitable.

Risks include wound weakness, suture problems, irregular astigmatism, infection, rejection, glaucoma, cataract, retinal complications, graft failure and serious loss of vision. The wound remains vulnerable to trauma even after sutures are removed.

Deep Anterior Lamellar Keratoplasty

DALK replaces diseased anterior corneal tissue while retaining the patient’s functioning endothelium. It may suit selected stromal disease such as keratoconus or scars that do not involve the deepest layers.

Avoiding donor endothelium reduces endothelial rejection risk but does not eliminate rejection of other layers, infection, interface haze, astigmatism or graft failure. Perforation can require conversion to a full-thickness transplant.

Endothelial Keratoplasty

DMEK and DSAEK/DSEK replace dysfunctional posterior corneal layers through an internal approach. A gas or air bubble usually supports attachment. They are used for selected endothelial disorders rather than stromal scars or keratoconus with a healthy endothelium.

Risks include partial graft detachment requiring another bubble procedure, tissue damage, pressure rise, inflammation, infection, rejection and failure. Positioning instructions and air-travel restrictions depend on the bubble and surgeon’s plan.

Donor Tissue and Screening

Corneas are donated after death and assessed by an authorised eye bank under applicable standards. Medical and social history, infectious-disease testing, tissue quality, endothelial cells and storage information help determine suitability.

No screening system removes every theoretical transmission risk. Donor identity is generally confidential, and tissue allocation and consent must follow local law. Eligibility for donation cannot be decided from a short internet list.

Assessment and Surgical Planning

Assessment can include vision and refraction, slit-lamp examination, corneal topography or tomography, thickness, endothelial-cell assessment, eye pressure, tear-film review and retinal or optic-nerve examination. Ultrasound may be required when the back of the eye cannot be seen.

The surgeon should explain which layer is diseased, why the proposed transplant is preferred, expected optical limitations, anaesthesia, graft source, combined procedures and what happens if the graft fails.

Rejection and Graft Failure

Rejection is an immune response to donor tissue; graft failure means the tissue no longer provides the required clarity or function and has several possible causes. Failure can occur without rejection, and treated rejection does not always cause failure.

Urgent warning signs include new redness, light sensitivity, pain or worsening vision. Contact the transplant team immediately rather than waiting for a routine appointment. Rejection risk differs by procedure, diagnosis, inflammation, blood vessels in the cornea and previous graft history.

Other Risks and Visual Limitations

Possible complications include infection inside or on the eye, bleeding, raised or low pressure, cataract, wound leak, sutures becoming loose or infected, retinal tear or detachment, macular swelling, double vision and need for further operations.

Glasses, contact lenses, suture adjustment or additional refractive treatment may be needed for astigmatism. Retinal, optic-nerve or amblyopic limitation can prevent good vision even when the cornea is clear.

Recovery and Long-Term Care

Visual recovery depends on transplant type, sutures, astigmatism, other eye conditions and healing. Do not use a generic timetable for work, driving, lifting, swimming, flying or contact sport.

Use drops exactly as prescribed; steroid treatment may continue for a prolonged period and can raise eye pressure or contribute to cataract. Do not stop it abruptly without advice. Eye protection, follow-up and prompt review of symptoms remain important long after surgery.

Cornea Donation

Donation decisions and eligibility should be based on official national guidance rather than promotional statistics. Many people who cannot donate some organs may still be able to donate corneas, but authorised teams make the final assessment.

People wishing to record a donation decision in the United Kingdom can use NHS Blood and Transplant information. Rules differ by country and should not be inferred from another jurisdiction’s donor criteria.

Planning Care Through Revitalize

Confirm the corneal surgeon’s full name, professional registration and procedure-specific experience, the contracted facility, licensed eye-bank source, technique, follow-up and emergency arrangements. Ask who manages rejection or graft detachment after return home.

For help organising records and a named-specialist assessment, contact Revitalize support. Travel must not delay treatment of active infection, perforation or rejection symptoms.

Independent Patient Information

Frequently Asked Questions

Does a donor cornea last for life?

Not necessarily. Longevity varies and late rejection, endothelial loss or other failure can require more treatment.

Is DMEK suitable for every corneal disease?

No. It replaces endothelial layers and does not treat disease confined to other layers.

When are rejection symptoms urgent?

New redness, light sensitivity, pain or worsening vision after a graft requires immediate contact with the transplant team.

Upcoming UK Meetings